The North American PDX Models Market (2018-2025): Company Profiles, Size, Share, Growth, Trends and Segment Forecasts – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “North
America PDX Models Market – Companies Profiles, Size, Share, Growth,
Trends and Forecast to 2025”
report has been added to ResearchAndMarkets.com’s
offering.

North America PDX models market is expected to hold the leading market
share in the forecast period of 2018 to 2025.

Prominent factors driving the growth of this market consist of rising
number of pharmaceutical R&D activities in cancer research, advantages
offered by PDX models offer compared with the classic approach, rising
need for personalized medicine and increasing support for cancer
research activities from government and non-government organization.

The North America PDX models market is segmented based on type into two
notable segments; mice models and rat models. In 2018, mice models
segment is valued to rule with the highest market share by 2025.

The North America PDX models market is segmented in tumor type
categories into six notable segments; respiratory tumor models,
urological tumor models, gastrointestinal tumor models, hematological
tumor models, gynecological tumor models and others. In 2018,
respiratory tumor models segment is valued to rule with the highest
market shares by 2025, rising at the highest CAGR.

The North America PDX models market is segmented in application into
preclinical drug development and oncology research and biomarker
analysis. In 2018, preclinical drug development and oncology research
segment is valued to rule with highest market shares and rising at the
highest CAGR.

The North America PDX models market is segmented in end user into
contract research organization (CRO), academic and research institutions
and pharmaceutical and biotechnology companies. In 2018, contract
research organization (CRO) segment is valued to rule with highest
market shares and rising at the highest CAGR.
Key Players

  • Crown Bioscience Inc.
  • The Jackson Laboratory
  • Champion Oncology Inc.
  • Charles River
  • Oncodesign
  • Wuxi AppTec
  • Horizon Discovery Group plc
  • Pharmatest Services
  • Hera Biolabs
  • EPO Berlin-Buch GmbH
  • Xentech
  • Urolead
  • Creative Animodel
  • EUROPDX
  • MI Bioresearch Inc.
  • Aragen Bioscience

Key Topics Covered

1 Introduction

2 Market Segmentation

3 Market Overview

4 Executive Summary

5 Premium Insights

6 North America PDX Models Market, by Type

7 North America PDX Models Market, by Tumor Type

8 North America PDX Models Market, by Application

9 North America PDX Models Market, by End User

10 North America PDX Models Market, by Geography

11 North America PDX Models Market, Company Landscape

12 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/wnlmnx/the_north?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Drug
Discovery